NU-RISE
NU-RISE S.A. is a Portuguese medical device company that develops the FDA-cleared PRO-DOSE system and NR-01 hardware for real-time radiation monitoring and in vivo dosimetry in HDR brachytherapy, serving radiotherapy clinics, cancer centers, and hospitals worldwide.
- Company typePrivate
- Founded2015
- HeadquartersAveiro, Portugal
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
NU-RISE firmographics
Firmographics- Name
- NU-RISE
- Legal name
- NU-RISE S.A.
- Website
- https://nu-rise.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- NU-RISE S.A. is a Portuguese medical device company that develops the FDA-cleared PRO-DOSE system and NR-01 hardware for real-time radiation monitoring and in vivo dosimetry in HDR brachytherapy, serving radiotherapy clinics, cancer centers, and hospitals worldwide.
- Ownership category
- akta.pro rank
NU-RISE industry classification
Industry- Product category
- Radiotherapy Medical Devices
- NAICS
- Irradiation Apparatus Manufacturing (334517)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiation Dose Management & Analytics (HLACALAH)
- akta.pro secondary industries
- Radiation Measurement, Dosimetry & Monitoring Services (Personal/environmental dosimetry, calibration labs) (EUAKAIAH), Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine) (HLAIAGAJ)
Keywords
Where NU-RISE is headquartered
LocationHeadquarters
- HQ city
- Aveiro
- HQ country
- Portugal
- HQ region
- Europe
Offices1 record
Markets served
NU-RISE business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- PRO-DOSE Medical Device Sales: Sale of FDA-cleared PRO-DOSE hardware systems to radiotherapy clinics, hospitals, and cancer treatment centers for real-time radiation monitoring and treatment verification.
- OEM / Commercial Partnerships: Partnerships with medical device companies for OEM integration or commercial distribution of the PRO-DOSE technology.
- Clinical Implementation Services: Professional services for workflow integration, training, and ongoing support for clinical implementation of the PRO-DOSE system.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
NU-RISE product offering
Product offeringCore offering
NU-RISE develops and sells the FDA-cleared PRO-DOSE System, a medical device for real-time radiation monitoring, in vivo dosimetry, and treatment verification in radiotherapy. The system pairs the PRO-DOSE software platform with the NR-01 hardware device to enable direct measurement of radiation dose delivered to patient tissue during treatment, with a specific focus on HDR brachytherapy quality assurance. The company targets radiotherapy clinics, cancer treatment centers, and hospitals, and also pursues OEM and commercial partnerships for broader distribution.
Differentiator
Problem solved
Functional benefit
Products and services
- PRO-DOSE System FDA-cleared in vivo dosimetry and treatment verification system for HDR brachytherapy quality assurance, enabling real-time monitoring of radiation delivery to improve safety and precision while reducing treatment sessions. Targeted at radiotherapy clinics, cancer treatment centers, and hospitals.
- NR-01 Device Hardware device used in conjunction with the PRO-DOSE system for radiation dosimetry and treatment verification applications in radiotherapy.
Quantifiable outcome
- Reduced treatment sessions while maintaining treatment precision
- +1 more outcomes
Companies that use NU-RISE
Customer profileSegments1 record
Ideal customer profiles1 record
NU-RISE technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
NU-RISE partnerships and signals
Strategic signalScale indicators3 records
NU-RISE competitors and assessment
Company assessmentDirect peers
- Modus Medical Devices: Designs QA phantoms and software for radiation therapy and brachytherapy. Overlaps with NU-RISE in brachytherapy-specific QA and treatment verification.
- Standard Imaging: US-based developer of QA instruments and phantoms for radiation therapy, including patient-specific QA tools. Directly comparable as a mid-sized specialist in radiotherapy QA hardware.
- PTW Freiburg: Long-established manufacturer of dosimetry equipment and detectors for radiation therapy and diagnostic radiology. Competes in patient QA detectors and in vivo dosimetry used during radiotherapy.
- Sun Nuclear (Mirion Technologies): Leading provider of patient-specific QA solutions for radiation oncology, including in vivo dosimetry and 3D QA. Closest direct competitor in radiotherapy patient QA, overlapping directly with PRO-DOSE's clinical workflow.
- IBA Dosimetry: Specializes in dosimetry and QA solutions for radiotherapy, including in vivo dosimetry systems (e.g., myQA). Directly competes with PRO-DOSE in radiation delivery verification and QA.
Broad incumbents
- Varian (Siemens Healthineers): Global leader in radiotherapy treatment delivery systems (linacs, brachytherapy afterloaders) and oncology software. Indirectly competing by integrating QA into its treatment ecosystem.
- Elekta: Major radiotherapy systems provider (linacs, brachytherapy solutions, Gamma Knife). Competes broadly in the radiation oncology value chain and shapes QA purchasing decisions.
- Accuray: Developer of CyberKnife and TomoTherapy systems for radiation therapy. Broad incumbent whose installed base creates demand for compatible QA/dosimetry products such as those offered by NU-RISE.
- Mirion Technologies: Parent of Sun Nuclear and broader radiation detection/dosimetry company spanning medical, industrial, and nuclear markets. Sets competitive context through its medical division while offering capital and scale.
Emerging players
- RTsafe: Specialist in patient-specific QA for radiotherapy, with 3D-printed phantoms and dosimetry verification. Emerging niche player addressing similar safety/verification use cases in radiation oncology.
Market position
Customer concentration
NU-RISE social profiles
Digital presenceNU-RISE compliance and trust
Trust signalCompliance1 record
NU-RISE financial estimates
Financial estimateRevenue estimate
Valuation estimate
NU-RISE leadership team
Management profileNumber of profiles
Profiles2 records
NU-RISE funding detail
Funding detailFunding overview
Funding rounds6 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NU-RISE M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NU-RISE
What does NU-RISE do?
NU-RISE develops and sells the FDA-cleared PRO-DOSE System, a medical device for real-time radiation monitoring, in vivo dosimetry, and treatment verification in radiotherapy. The system pairs the PRO-DOSE software platform with the NR-01 hardware device to enable direct measurement of radiation dose delivered to patient tissue during treatment, with a specific focus on HDR brachytherapy quality assurance. The company targets radiotherapy clinics, cancer treatment centers, and hospitals, and also pursues OEM and commercial partnerships for broader distribution.
Is NU-RISE a public or private company?
NU-RISE is a private company. It is classified as venture growth investor backed and is currently operating.
When was NU-RISE founded?
NU-RISE was founded in 2015. It employs 1 to 10 people.
Where is NU-RISE based?
NU-RISE is headquartered in Aveiro, Portugal, in the Europe region.
How does NU-RISE make money?
Three revenue lines are on record. PRO-DOSE Medical Device Sales are the primary driver. The others are OEM / Commercial Partnerships and clinical Implementation Services.
Who are NU-RISE's main competitors?
Direct peers on record are Modus Medical Devices, Standard Imaging, PTW Freiburg, Sun Nuclear (Mirion Technologies) and IBA Dosimetry. Broad incumbents are Varian (Siemens Healthineers), Elekta, Accuray and Mirion Technologies. RTsafe is listed as an emerging player.
Does NU-RISE have an API?
No public API is recorded for NU-RISE.
What industry is NU-RISE in?
NU-RISE's product category is Radiotherapy Medical Devices. Its primary akta.pro industry code is HLACALAH, Radiation Dose Management & Analytics, with a secondary code of EUAKAIAH, Radiation Measurement, Dosimetry & Monitoring Services (Personal/environmental dosimetry, calibration labs). Its NAICS code is 334517 and its SIC code is 3841.